Published in J Hematother on April 01, 1997
Circulating tumors cells as biomarkers: progress toward biomarker qualification. Cancer J (2011) 1.25
Differential interaction of magnetic nanoparticles with tumor cells and peripheral blood cells. J Cancer Res Clin Oncol (2006) 0.97
CTC enumeration and characterization: moving toward personalized medicine. Ann Transl Med (2014) 0.94
Detection of circulating tumour cells in patients with breast or ovarian cancer by molecular cytogenetics. Br J Cancer (1999) 0.89
Immunomagnetic enrichment of disseminated tumor cells in bone marrow and blood of breast cancer patients by the Thomsen-Friedenreich-Antigen. Clin Exp Metastasis (2008) 0.86
Gene expression of circulating tumour cells in breast cancer patients. Eur J Med Res (2009) 0.84
Characterisation of disseminated tumor cells in the bone marrow of breast cancer patients by the Thomsen-Friedenreich tumor antigen. Histochem Cell Biol (2005) 0.82
Head and neck cancer and precancer: can we use molecular genetics to make better predictions? Ann R Coll Surg Engl (1999) 0.78
Prognostic value of hematogenous dissemination and biological profile of the tumor in early breast cancer patients: a prospective observational study. BMC Cancer (2011) 0.78
Sensitive fluorescent in situ hybridisation method for the characterisation of breast cancer cells in bone marrow aspirates. Mol Pathol (1999) 0.77
Technical Insights into Highly Sensitive Isolation and Molecular Characterization of Fixed and Live Circulating Tumor Cells for Early Detection of Tumor Invasion. PLoS One (2017) 0.75
Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am J Pathol (2001) 3.55
Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer. J Clin Oncol (2003) 2.13
Homocysteine and other thiols in plasma and urine: automated determination and sample stability. Clin Chem (1993) 2.07
Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells. Cytotherapy (1999) 1.83
HLA class I and II typing using cells positively selected from blood by immunomagnetic isolation--a fast and reliable technique. Tissue Antigens (1986) 1.67
Persistent changes in the immune system 4-10 years after ABMT. Bone Marrow Transplant (1999) 1.44
[High-dose autologous stem cell support in malignant diseases--an established method, uncertain indication]. Tidsskr Nor Laegeforen (1994) 1.39
Isolation and characterization of human hematopoietic progenitor cells: an effective method for positive selection of CD34+ cells. Leukemia (1992) 1.39
The specific induction of myc protooncogene expression in normal human B cells is not a sufficient event for acquisition of competence to proliferate. Proc Natl Acad Sci U S A (1985) 1.34
Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: A dose escalating phase I/II study. Br J Cancer (2006) 1.29
Interleukin 4 induces selective production of interleukin 6 from normal human B lymphocytes. J Exp Med (1989) 1.26
Epitopes of the Mycobacterium tuberculosis 65-kilodalton protein antigen as recognized by human T cells. J Immunol (1988) 1.26
Direct immunomagnetic quantification of lymphocyte subsets in blood. Clin Exp Immunol (1988) 1.24
Changing molecular epidemiology of methicillin-resistant Staphylococcus aureus in a small geographic area over an eight-year period. J Clin Microbiol (2007) 1.24
Immunocytochemical detection of isolated epithelial cells in bone marrow: non-specific staining and contribution by plasma cells directly reactive to alkaline phosphatase. J Pathol (1998) 1.23
Depletion of T lymphocytes from human bone marrow. Use of magnetic monosized polymer microspheres coated with T-lymphocyte-specific monoclonal antibodies. Transplantation (1987) 1.20
TGF-beta 1 and cyclic AMP promote apoptosis in resting human B lymphocytes. J Immunol (1995) 1.16
DNA replication in Physarum polycephalum: electron microscopic and autoradiographic analysis of replicating DNA from defined stages of the S-period. Nucleic Acids Res (1979) 1.14
Characterization of human mononuclear cells after positive selection with immunomagnetic particles. Scand J Immunol (1986) 1.11
Size distribution and maturation of newly replicated DNA through the S and G2 phases of Physarum polycephalum. Cell (1978) 1.11
Characterization of two murine monoclonal antibodies reactive with human B cells. Their use in a high-yield, high-purity method for isolation of B cells and utilization of such cells in an assay for B-cell stimulating factor. Scand J Immunol (1985) 1.10
Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study). Br J Cancer (2011) 1.09
Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA. Cancer Gene Ther (2006) 1.08
Detection of isolated tumor cells in bone marrow in early-stage breast carcinoma patients: comparison with preoperative clinical parameters and primary tumor characteristics. Clin Cancer Res (2001) 1.06
Functional and specific antibody responses in adult volunteers in new zealand who were given one of two different meningococcal serogroup B outer membrane vesicle vaccines. Clin Vaccine Immunol (2007) 1.05
Low-grade intestinal lymphoma of intraepithelial T lymphocytes with concomitant enteropathy-associated T cell lymphoma: case report suggesting a possible histogenetic relationship. Hum Pathol (1989) 1.04
Independent regulation of 55-kDa and 75-kDa tumor necrosis factor receptors during activation of human peripheral blood B lymphocytes. Eur J Immunol (1991) 1.04
Disseminated tumour cells as a prognostic biomarker in colorectal cancer. Br J Cancer (2011) 1.04
Transforming growth factor type beta (TGF beta) inhibits G1 to S transition, but not activation of human B lymphocytes. Exp Cell Res (1987) 1.02
Comparison of functional immune responses in humans after intranasal and intramuscular immunisations with outer membrane vesicle vaccines against group B meningococcal disease. Vaccine (2003) 1.02
Human B-cell neoplasms in relation to normal B-cell differentiation and maturation processes. Adv Cancer Res (1982) 1.02
Histogram analysis of MR imaging-derived cerebral blood volume maps: combined glioma grading and identification of low-grade oligodendroglial subtypes. AJNR Am J Neuroradiol (2008) 1.02
Increased sensitivity for detection of micrometastases in bone-marrow/peripheral-blood stem-cell products from breast-cancer patients by negative immunomagnetic separation. Int J Cancer (1998) 1.01
Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies. Evaluation of five epithelial markers. Virchows Arch (1999) 1.01
A new method for detachment of Dynabeads from positively selected B lymphocytes. J Immunol Methods (1992) 1.01
The role of plerixafor in optimizing peripheral blood stem cell mobilization for autologous stem cell transplantation. Leukemia (2011) 1.01
A splice variant of human ephrin-A4 encodes a soluble molecule that is secreted by activated human B lymphocytes. Blood (2000) 1.00
Elimination of B-lymphoma cells from human bone marrow: model experiments using monodisperse magnetic particles coated with primary monoclonal antibodies. Cancer Res (1987) 1.00
Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients. Br J Cancer (2005) 1.00
DNA replication in Physarum polycephalum: characterization of DNA replication products made in vivo in the presence of cycloheximide in strains sensitive and resistant to cycloheximide. Nucleic Acids Res (1977) 0.99
Monosized, magnetic polymer particles: their use in separation of cells and subcellular components, and in the study of lymphocyte function in vitro. J Mol Recognit (1988) 0.99
Mycobacterium bovis BCG-induced human T-cell clones from BCG-vaccinated healthy subjects: antigen specificity and lymphokine production. Infect Immun (1986) 0.98
DNA replication in Physarum polycephalum: bidirectional replication of DNA within replicons. Nucleic Acids Res (1978) 0.97
Cyclic AMP-dependent protein kinase (cAK) in human B cells: co-localization of type I cAK (RI alpha 2 C2) with the antigen receptor during anti-immunoglobulin-induced B cell activation. Eur J Immunol (1996) 0.96
Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: results of the SIOPEN study. Eur J Cancer (2013) 0.95
Selection of anti-SCLC antibodies for diagnosis of bone marrow metastasis. Br J Cancer Suppl (1991) 0.94
DNA replication in Physarum polycephalum: characterization of replication products in vivo. Nucleic Acids Res (1975) 0.94
T-zone lymphoma with predominance of 'plasmacytoid T-cells' associated with myelomonocytic leukaemia--a distinct clinicopathological entity. J Pathol (1986) 0.94
DNA replication in Physarum polycephalum: UV photolysis of maturing 5-bromo-deoxyuridine substituted DNA. Nucleic Acids Res (1978) 0.94
The great majority of childhood lymphoblastic leukaemias are identified by monoclonal antibodies as neoplasias of the B-cell progenitor compartment. Scand J Haematol (1984) 0.93
Treatment of Burkitt's/Burkitt-like lymphoma in adolescents and adults: a 20-year experience from the Norwegian Radium Hospital with the use of three successive regimens. Ann Oncol (2004) 0.93
A protocol for generation of clinical grade mRNA-transfected monocyte-derived dendritic cells for cancer vaccines. Scand J Immunol (2003) 0.93
New monoclonal antibodies specific for human sarcomas. Int J Cancer (1986) 0.93
The B cell antigen CD75 is a cell surface sialytransferase. J Exp Med (1990) 0.92
Transferrin receptor and B-lymphoblast antigen--their relationship to DNA synthesis, histology and survival in B-cell lymphomas. Int J Cancer (1984) 0.92
Survival of breast cancer patients diagnosed during pregnancy or lactation. Br J Cancer (1988) 0.92
Single cell studies on the immunological marker profile of plasmacytoid T-zone cells. Lab Invest (1987) 0.92
Detection of isolated tumor cells in peripheral blood and in BM: evaluation of a new enrichment method. Cytotherapy (2004) 0.92
The four mouse IgG isotypes differ extensively in bactericidal and opsonophagocytic activity when reacting with the P1.16 epitope on the outer membrane PorA protein of Neisseria meningitidis. Scand J Immunol (2004) 0.92
Ki67 and 4F2 antigen expression as well as DNA synthesis predict survival at relapse/tumour progression in low-grade B-cell lymphoma. Int J Cancer (1989) 0.91
Characteristic appearances of the bone marrow in T-cell large granular lymphocyte leukaemia. Histopathology (2007) 0.90
The nature of the subset of MHC class II molecules carrying the CDw78 epitopes. Int Immunol (1999) 0.88
Detection of isolated tumor cells in BM from breast-cancer patients: significance of anterior and posterior iliac crest aspirations and the number of mononuclear cells analyzed. Cytotherapy (2003) 0.87
Binding properties and anti-bacterial activities of V-region identical, human IgG and IgM antibodies, against group B Neisseria meningitidis. Biochem Soc Trans (2003) 0.87
High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas. Bone Marrow Transplant (2001) 0.87
Cyclic AMP-mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes. J Cell Physiol (1987) 0.86
All-trans- and 9-cis-retinoic acid inhibit growth of normal human and murine B cell precursors. J Immunol (1995) 0.86
Mycobacterial crossreactivity of M. tuberculosis reactive T cell clones from naturally converted PPD positive healthy subjects. FEMS Immunol Med Microbiol (1998) 0.86
All-trans retinoic acid directly inhibits granulocyte colony-stimulating factor-induced proliferation of CD34+ human hematopoietic progenitor cells. Blood (1994) 0.84
Demonstration of highly specific toxicity of the alpha-emitting radioimmunoconjugate(211)At-rituximab against non-Hodgkin's lymphoma cells. Br J Cancer (2000) 0.84
Granulocyte colony-stimulating factor improves myelopoiesis and host defense in fulminant intra-abdominal sepsis in rats. Shock (1995) 0.84
Inhibition of polyphosphoinositide breakdown and c-myc induction accompanying inhibition of human B-cell activation by two monoclonal antibodies against the leucocyte common antigen (CD45). Scand J Immunol (1990) 0.84
Regulation of c-myc transcription and protein expression during activation of normal human B cells. Exp Cell Res (1987) 0.84
Intracellular events associated with inhibition of B cell activation by monoclonal antibodies to HLA class II antigens. Eur J Immunol (1989) 0.84
Infused CD34 cell dose, but not tumour cell content of peripheral blood progenitor cell grafts, predicts clinical outcome in patients with diffuse large B-cell lymphoma and follicular lymphoma grade 3 treated with high-dose therapy. Br J Haematol (2004) 0.84
Activation of human B cells: alternate options for initial triggering and effects of nonmitogenic concentrations of anti-IgM antibodies on resting and activated cells. J Immunol (1987) 0.83
Immunomagnetic isolation of NK and LAK cells. J Immunol Methods (1991) 0.83
Different responses elicited in vitro by antibodies to IgM and IgD in cells from a surface IgM + D-positive human follicular lymphoma. Scand J Immunol (1983) 0.83
A European interlaboratory testing of three well-known procedures for immunocytochemical detection of epithelial cells in bone marrow. Results from analysis of normal bone marrow. Cytometry B Clin Cytom (2006) 0.82
Triggering of monoclonal human lymphoma B cells with antibodies to IgM heavy chains: differences of response obtained with monoclonal as compared to polyclonal antibodies. Clin Exp Immunol (1983) 0.82
Leucocyte depletion filter removes cancer cells in human blood. Acta Anaesthesiol Scand (1996) 0.82